Grants and Contributions:
Agreement Number:
-
Agreement Value:
$573,375.00
Agreement Date:
Jul 1, 2016 - Jun 30, 2021
Description:
Evaluation of the anti-angiogenic and neuroprotective effects of the BMP antagonist COCO for the treatment of neovascular ocular pathologies.
Organization:
Canadian Institutes of Health Research
Location:
Montréal, Quebec, CA H1T 2M4
Reference Number:
236-2016-2017-Q2-00024
Agreement Type:
Grant
Report Type:
Grants and Contributions
Additional Information:
Grant or Award spanning more than one fiscal year.
(2016-17 to 2021-22)
Recipient's Legal Name:
Larrivee, Bruno
Research Organization:
Hôpital Maisonneuve-Rosemont - CIUSSS EIM (Montréal)